Gene Therapy – Ready for the Market?

The last years were very promising for gene therapeutic approaches. A number of successful treatments of cancer or rare diseases were reported, as well as FDA approval of first gene therapeutic products. Until now, these pioneering treatments have been used primarily when conventional therapies reach their limits. Development, manufacturing, quality control and clinical application of gene therapeutic products are very challenging – and still far from routine. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)